On September 23, 2020, Department of Health and Human Services Alex Azar submitted a letter to House Minority Leader Kevin McCarthy certifying that Canadian drug importation would pose not additional threats to consumers and would save Americans a significant amount of money on prescription drugs.
Read MoreTrump Administration Defies 20 Years of FDA Expertise and Guidance in Finalizing Politically Motivated Drug Importation Rule Washington, D.C. (September 24, 2020) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to the Trump Administration’s Final Rule issued today on the importation of prescription drugs: “With 40…
Read More
On September 24th, 2020 the U.S. Department of Health and Human Services released a draft of finalized rulemaking for Importation of Prescription Drugs. Watch this space for the most up-to-date news.
Read More
Last June, police in Ontario, Canada carried out Project Javelin, shutting down a huge counterfeiting operation that manufactured hundreds of thousands of fentanyl pills disguised as Oxycocet, a Health Canada-approved generic oxycodone and acetaminophen product with the same ingredients as Percocet.
Update: Executive Director Shabbir Safdar followed up with retired Chief Superintendent of the Ontario Police Don Bell to talk about the impact these criminals could have had. Watch that interview in our September 23rd video, “Deadly Pills in Ontario.”
Read More
In PSM’s round-up this week: 520,000 fake medical masks seized by Customs and Border Protection, another fake online pharmacy case, and a flood of news about counterfeit pills made with fentanyl.
Read More
Risk Statement: Patients being treated for hypothyroidism (underactive thyroid), who receive sub potent NP Thyroid®, may experience signs and symptoms of hypothyroidism (underactive thyroid) which may include, fatigue, increased sensitivity to cold, constipation, dry skin, puffy face, hair loss, slow heart rate, depression, swelling of the thyroid gland and/or unexplained weight gain or difficulty losing weight. There is reasonable risk of serious injury in newborn infants or pregnant women with hypothyroidism including early miscarriage, fetal hyperthyroidism, and/or impairments to fetal neural and skeletal development. In elderly patients and patients with underlying cardiac disease toxic cardiac manifestations of hyperthyroidism may occur, such as cardiac pain, palpitations or cardiac arrhythmia. To date, Acella has received four reports of adverse events for these lot numbers possibly related to this recall.
Read More
In PSM’s round-up this week: $132 million in losses from #covidscams since March, fake online pharmacies selling counterfeit and non-FDA approved opioids, Operation Quack Hack, and more.
Read More
In PSM’s round-up this week: outrageous COVID-19-related financial fraud, fake treatments, and the week in deadly counterfeit pills.
Read More
If you are taking a life-saving HIV medication right now, or any kind of life saving medication, you may be concerned about how to be certain that your supply of medicine is secure. In this post, William Arnold of the Community Access National Network , PSM’s Shabbir Safdar, and Brandon M. Macsata of ADAP Advocacy Association offer suggestions to help.
Read More
Risk Statement: Patients being treated for hypothyroidism (underactive thyroid), who receive sub potent Nature-Throid® or WP Thyroid®, may experience signs and symptoms of hypothyroidism (underactive thyroid) which may include, fatigue, increased sensitivity to cold, constipation, dry skin, puffy face, hair loss, slow heart rate, depression, swelling of the thyroid gland and/or unexplained weight gain or difficulty losing weight.
Read More